glutamine has been researched along with Parkinson Disease in 45 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.22) | 18.7374 |
| 1990's | 6 (13.33) | 18.2507 |
| 2000's | 12 (26.67) | 29.6817 |
| 2010's | 17 (37.78) | 24.3611 |
| 2020's | 9 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boumezbeur, F; Chassain, C; Cladiere, A; Debilly, B; Durif, F; Marques, AR; Pereira, B; Thobois, S; Tsoutsos, C | 1 |
| Li, R; Shi, W; Yan, Z; Yao, L | 1 |
| Banerjee, R; Datta, I; Holla, V; Kamble, N; Kumar Pal, P; Potdar, C; Raj, A; Yadav, R | 1 |
| Cheng, JY; Deng, YT; Yu, JT | 1 |
| Fu, J; Gao, X; Liu, S; Lu, F; Lu, Y; Mohammed, SAD; Nan, Y; Wang, T; Wang, Y | 1 |
| Fayaz, SM; Gurram, PC; Kodi, T; Nampoothiri, M; Nassar, A; Satarker, S | 1 |
| Butterfield, DA; Hinchie, A; Powell, DK; Ren, X; Swomley, A | 1 |
| Aiello, C; Bonanni, L; Bubbico, G; Calvanese, F; Delli Pizzi, S; Edden, RAE; Esposito, R; Ferretti, A; Franciotti, R; Onofrj, M; Sensi, SL; Tartaro, A; Zöllner, HJ | 1 |
| Aulakh, S; Tripathi, M | 1 |
| Beach, TG; Bluhm, A; Coras, R; Hartlage-Rübsamen, M; Hilbrich, I; Holzer, M; Köppen, J; Machner, L; Moceri, S; Richter, F; Roßner, S; Schenk, M; Schilling, S; Schulze, A; Serrano, GE; von Hörsten, S; Weidenfeller, M; Xiang, W | 1 |
| Baekelandt, V; Casteels, C; Crabbé, M; Himmelreich, U; Van der Perren, A; Van Laere, K; Weerasekera, A | 1 |
| Ancona, E; Barassi, G; Bellomo, RG; Bonanni, L; Carmignano, SM; Delli Pizzi, S; Franciotti, R; Onofrj, M; Saggini, R; Supplizi, M | 1 |
| Baumann, CR; Baumann-Vogel, H; O'Gorman Tuura, RL | 1 |
| Chatterji, T; Gupta, M; Nagesh Babu, G; Paliwal, VK; Roy, R; Singh, S | 1 |
| Li, J; Liu, Z; Lu, G; Wang, Q; Wang, Y; Zhao, Y | 1 |
| Apetri, M; Christiansen, G; Hrle, D; Otzen, DE; Rammes, G; Tepper, A; van Diggelen, F | 1 |
| Aasly, JO; Appel-Cresswell, S; Encarnacion, M; Farrer, MJ; Jon Stoessl, A; Rajput, A; Rajput, AH; Shah, B; Sherman, H; Szu-Tu, C; Thompson, C; Trinh, J; Vilarino-Guell, C; Weir, D; Yu, I | 1 |
| Alcalay, RN; Bressman, SB; Clark, L; Doan, N; Giladi, N; Glickman, A; Johannes, B; Luciano, MS; Marder, K; Mejia-Santana, H; Mirelman, A; Orr-Utreger, A; Ortega, RA; Ozelius, L; Raymond, D; Saunders-Pullman, R; Wang, C; Yasinovsky, K | 1 |
| Chiappe, D; Grimminger, V; Hang, I; Lashuel, HA; Moniatte, M; Pignat, V; Schmid, AW | 1 |
| Bolaño, MJ; Ferrer, I; Gorostidi, A; López de Munain, A; Martí-Massó, JF; Moreno, F; Ruiz, I; Ruiz-Martínez, J | 1 |
| Eerola, J; Luoma, PT; Paisan-Ruiz, C; Peuralinna, T; Scholz, S; Singleton, AB; Suomalainen, A; Tienari, PJ | 1 |
| Clément, O; Fort, P; Gervasoni, D; Léger, L; Luppi, PH; Peyron, C; Salvert, D; Sapin, E | 1 |
| Artal, J; Fayed, N; Modrego, PJ; Olmos, S | 1 |
| Acosta, O; Alvarez, V; Avello, R; Bacon, JA; Cornejo-Olivas, M; Cosentino, C; Díaz-Grez, F; Dieguez, E; Farrer, MJ; Layson, L; Marca, V; Mata, IF; Mazzetti, P; Medina, AC; Micheli, F; Miranda, M; Ortega, O; Perandones, C; Perez-Pastene, C; Raggio, V; Ross, OA; Segura-Aguilar, J; Torres, L; Trujillo-Godoy, O; Venegas, P; Vilariño-Güell, C; Wilhoite, GJ; Yearout, D; Zabetian, CP | 1 |
| Gomez-Esteban, JC; Lezcano, E; Molano, A; Somme, JH; Tijero, B; Zarranz, JJ | 1 |
| Bai, GH; Gao, HC; Li, XK; Lin, L; Song, CY; Xiang, Y; Yan, ZH; Ye, FQ; Zhu, H | 1 |
| Ariga, H; Iguchi-Ariga, SM; Maita, C; Maita, H | 1 |
| Aschner, M; Sidoryk-Wegrzynowicz, M | 1 |
| Clarimon, J; Eerola, J; Hellström, O; Singleton, A; Tienari, PJ | 1 |
| Aasly, J; Gårseth, M; Sonnewald, U; White, LR | 1 |
| Conrads, TP; Johnson, MD; Kinoshita, Y; McBee, JK; Morrison, RS; Uo, T; Veenstra, TD; Yu, LR | 1 |
| Dekomien, G; Epplen, JT; Kurz, M; Larsen, JP; Mueller, T; Schlitter, AM; Woitalla, D | 1 |
| An, X; Arbuthnott, GW; Day, M; Deutch, AY; Ding, J; Ilijic, E; Ingham, CA; Mugnaini, E; Sampson, AR; Sesack, SR; Shering, AF; Sun, Z; Surmeier, DJ; Wang, Z; Wokosin, D | 1 |
| Aasly, JO; Adler, CH; Blazquez, M; Farrer, MJ; Gibson, JM; Gwinn-Hardy, K; Haugarvoll, K; Hulihan, MM; Kachergus, J; Lynch, T; Mata, IF; Ross, OA; Stone, JT; Toft, M; White, LR | 1 |
| Durif, F; Fraix, V; Kickler, N; Krack, P; Krainik, A; Lamalle, L; Lebas, JF; Pollak, P; Rémy, C; Segebarth, C | 1 |
| Hayashi, H; Kagamihara, Y; Kawata, A; Matsubara, S; Sugaya, K | 1 |
| Baldy-Moulinier, M; Billiard, M; Camu, W | 1 |
| Hornykiewicz, O | 1 |
| Arenas, J; Benito-León, J; Cisneros, E; Gasalla, T; Gómez, P; Jiménez-Jiménez, FJ; Molina, JA; Navarro, JA; Ortí-Pareja, M; Vargas, C | 1 |
| Bhattacharya, S; Brooks, DJ; Bryant, DJ; Cox, IJ; Sargentoni, J; Seery, JP; Taylor-Robinson, SD; Turjanski, N | 1 |
| Akhmedova, S; Anisimov, S; Schwartz, E; Yakimovsky, A | 1 |
| Iwata, S; Nomoto, M | 1 |
| Clarke, CE; Lowry, M | 1 |
| Girault, JA; Greengard, P; Halpain, S | 1 |
| Bruck, J; Gerstenbrand, F; Gnad, H; Gründig, E; Prosenz, P; Teuflmayr, R | 1 |
6 review(s) available for glutamine and Parkinson Disease
| Article | Year |
|---|---|
Astrocytic transcription factors REST, YY1, and putative microRNAs in Parkinson's disease and advanced therapeutic strategies.
Topics: Astrocytes; Glutamine; Humans; MicroRNAs; Parkinson Disease; Transcription Factors; YY1 Transcription Factor | 2024 |
The neuronal network responsible for paradoxical sleep and its dysfunctions causing narcolepsy and rapid eye movement (REM) behavior disorder.
Topics: Amygdala; Animals; Brain; Brain Mapping; Cataplexy; Emotions; gamma-Aminobutyric Acid; Glutamine; Glycine; Humans; Hypothalamus; Medulla Oblongata; Motor Neurons; Muscle Tonus; Narcolepsy; Nerve Net; Neurodegenerative Diseases; Neurons; Parkinson Disease; Pedunculopontine Tegmental Nucleus; Pons; REM Sleep Behavior Disorder; Sleep, REM; Wakefulness | 2011 |
Manganese toxicity in the central nervous system: the glutamine/glutamate-γ-aminobutyric acid cycle.
Topics: Central Nervous System; Dementia; Evidence-Based Medicine; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Manganese; Parkinson Disease | 2013 |
The proteomics of neurodegeneration.
Topics: Alzheimer Disease; Animals; Down Syndrome; Glutamine; Humans; Motor Neuron Disease; Neurodegenerative Diseases; Parkinson Disease; Proteomics; tau Proteins; Trauma, Nervous System | 2005 |
Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms.
Topics: Corpus Striatum; Dopamine; Glutamine; Humans; Huntington Disease; Lesch-Nyhan Syndrome; Malignant Hyperthermia; Neurons; Parkinson Disease; Receptors, Dopamine; Receptors, Glutamate; Substantia Nigra | 1993 |
[Functions and metabolic rates of transmitters in the basal ganglia].
Topics: Acetylcholine; Animals; Basal Ganglia; Dopamine; Glutamine; Motor Neurons; Neurotransmitter Agents; Parkinson Disease; Serotonin | 2000 |
39 other study(ies) available for glutamine and Parkinson Disease
| Article | Year |
|---|---|
Glutamate cycle changes in the putamen of patients with de novo Parkinson's disease using
Topics: Animals; Glutamic Acid; Glutamine; Humans; Parkinson Disease; Proton Magnetic Resonance Spectroscopy; Putamen | 2022 |
Role of the gut-microbiota-metabolite axis in the rotenone model of early-stage Parkinson's Disease.
Topics: Alanine; Animals; Asparagine; Gastrointestinal Microbiome; Glutamine; Hydroxyproline; Methionine; Mice; Parkinson Disease; Rotenone; Serine; Threonine | 2022 |
Astrocytes Differentiated from LRRK2-I1371V Parkinson's-Disease-Induced Pluripotent Stem Cells Exhibit Similar Yield but Cell-Intrinsic Dysfunction in Glutamate Uptake and Metabolism, ATP Generation, and Nrf2-Mediated Glutathione Machinery.
Topics: Adenosine Triphosphate; Astrocytes; Glutamic Acid; Glutamine; Glutathione; Humans; Induced Pluripotent Stem Cells; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; NF-E2-Related Factor 2; Parkinson Disease | 2023 |
The causal role of circulating amino acids on neurodegenerative disorders: A two-sample Mendelian randomization study.
Topics: Alzheimer Disease; Amino Acids; Causality; Genome-Wide Association Study; Glutamine; Humans; Lewy Body Disease; Mendelian Randomization Analysis; Neurodegenerative Diseases; Parkinson Disease | 2023 |
Efficacy and mechanism study of Baichanting compound, a combination of Acanthopanax senticosus (Rupr. and Maxim.) Harms, Paeonia lactiflora Pall and Uncaria rhynchophylla (Miq.) Miq. ex Havil, on Parkinson's disease based on metagenomics and metabolomics.
Topics: Animals; Antioxidants; Chromatography, Liquid; Dopamine; Eleutherococcus; Glutamic Acid; Glutamine; Interleukin-6; Malondialdehyde; Metabolomics; Mice; Mice, Inbred C57BL; Paeonia; Parkinson Disease; Superoxide Dismutase; Tandem Mass Spectrometry; Tumor Necrosis Factor-alpha | 2024 |
Profiles of brain oxidative damage, ventricular alterations, and neurochemical metabolites in the striatum of PINK1 knockout rats as functions of age and gender: Relevance to Parkinson disease.
Topics: Animals; Aspartic Acid; Biomarkers; Brain; Corpus Striatum; Disease Models, Animal; Female; Gene Knockout Techniques; Glutamine; Glutathione; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Neurodegenerative Diseases; Oxidative Stress; Parkinson Disease; Protein Kinases; Rats; Taurine | 2019 |
High γ-Aminobutyric Acid Content Within the Medial Prefrontal Cortex Is a Functional Signature of Somatic Symptoms Disorder in Patients With Parkinson's Disease.
Topics: gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Medically Unexplained Symptoms; Parkinson Disease; Prefrontal Cortex | 2020 |
Is Glutamine Responsible for the Radiosensitivity of Subthalamic Nucleus?
Topics: Glutamine; Humans; Parkinson Disease; Radiation Tolerance; Subthalamic Nucleus; Thalamic Nuclei | 2021 |
A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies.
Topics: alpha-Synuclein; Aminoacyltransferases; Animals; Brain; Cell Survival; Chromatography, Gel; Dopaminergic Neurons; Glutamine; Humans; Kinetics; Lewy Body Disease; Mice; Mice, Transgenic; Parkinson Disease; Protein Processing, Post-Translational; Sambucus nigra; Synucleinopathies | 2021 |
Altered mGluR5 binding potential and glutamine concentration in the 6-OHDA rat model of acute Parkinson's disease and levodopa-induced dyskinesia.
Topics: Acute Disease; Animals; Cerebral Cortex; Disease Models, Animal; Dyskinesias; Female; Glutamine; Levodopa; Oxidopamine; Parkinson Disease; Positron-Emission Tomography; Proton Magnetic Resonance Spectroscopy; Putamen; Rats, Wistar; Receptor, Metabotropic Glutamate 5 | 2018 |
Rehabilitation program based on sensorimotor recovery improves the static and dynamic balance and modifies the basal ganglia neurochemistry: A pilot 1H-MRS study on Parkinson's disease patients.
Topics: Aged; Basal Ganglia; Female; Glutamic Acid; Glutamine; Humans; Male; Parkinson Disease; Pilot Projects; Postural Balance | 2017 |
Neurotransmitter activity is linked to outcome following subthalamic deep brain stimulation in Parkinson's disease.
Topics: Aged; Basal Ganglia; Deep Brain Stimulation; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Pons; Subthalamic Nucleus | 2018 |
Serum metabolomics study in a group of Parkinson's disease patients from northern India.
Topics: Aged; Alanine; Female; Glutamine; Histidine; Humans; India; Isoleucine; Male; Metabolomics; Middle Aged; Multiple System Atrophy; Parkinson Disease; Proton Magnetic Resonance Spectroscopy; Supranuclear Palsy, Progressive; Valine | 2018 |
Glutamine protects against oxidative stress injury through inhibiting the activation of PI3K/Akt signaling pathway in parkinsonian cell model.
Topics: 1-Methyl-4-phenylpyridinium; Analysis of Variance; Animals; Cell Culture Techniques; Disease Models, Animal; Glutamine; Oxidative Stress; Parkinson Disease; Phosphatidylinositol 3-Kinases; Protective Agents; Proto-Oncogene Proteins c-akt; Rats | 2019 |
Two conformationally distinct α-synuclein oligomers share common epitopes and the ability to impair long-term potentiation.
Topics: Aldehydes; alpha-Synuclein; Animals; Circular Dichroism; Docosahexaenoic Acids; Epitopes; Fatty Acids, Unsaturated; Fluoresceins; Glutamine; Hippocampus; Humans; Light; Lipid Peroxidation; Long-Term Potentiation; Male; Mice; Mice, Inbred C57BL; Microscopy, Atomic Force; Neurons; Parkinson Disease; Protein Binding; Protein Structure, Secondary; Rats; Scattering, Radiation; Spectroscopy, Fourier Transform Infrared; Synapses | 2019 |
Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease.
Topics: alpha-Synuclein; Glutamine; Histidine; Humans; Male; Middle Aged; Mutation; Parkinson Disease; Pedigree | 2013 |
REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers.
Topics: Adult; Aged; Female; Glutamine; Humans; Judaism; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Parkinson Disease; Protein Serine-Threonine Kinases; Serine; Sleep Deprivation; Surveys and Questionnaires | 2015 |
Dissecting the mechanisms of tissue transglutaminase-induced cross-linking of alpha-synuclein: implications for the pathogenesis of Parkinson disease.
Topics: alpha-Synuclein; Benzothiazoles; Circular Dichroism; Cross-Linking Reagents; Dimerization; Glutamine; Humans; Immunoblotting; Mutagenesis, Site-Directed; Mutation; Parkinson Disease; Protein Conformation; Spectrometry, Mass, Electrospray Ionization; Thiazoles; Transglutaminases | 2009 |
Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2.
Topics: Aged; Arginine; beta-Crystallin A Chain; DNA Mutational Analysis; Glutamine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Mutation; Nerve Tissue Proteins; Parkinson Disease; Protein Serine-Threonine Kinases; Substantia Nigra; tau Proteins; Ubiquitin | 2009 |
POLG1 polyglutamine tract variants associated with Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; DNA Polymerase gamma; DNA-Directed DNA Polymerase; Female; Genetic Association Studies; Genetic Predisposition to Disease; Glutamine; Humans; Male; Middle Aged; Parkinson Disease; Peptides; Trinucleotide Repeats; White People | 2010 |
Correlation of findings in advanced MRI techniques with global severity scales in patients with Parkinson disease.
Topics: Aged; Brain; Choline; Corpus Striatum; Creatine; Diffusion Tensor Imaging; Dipeptides; Female; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Parkinson Disease; Severity of Illness Index; Substantia Nigra | 2011 |
Lrrk2 p.Q1111H substitution and Parkinson's disease in Latin America.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Case-Control Studies; Female; Glutamine; Histidine; Humans; Indians, South American; Latin America; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Parkinson Disease; Protein Serine-Threonine Kinases; Young Adult | 2011 |
Initial neuropsychological impairments in patients with the E46K mutation of the α-synuclein gene (PARK 1).
Topics: Aged; Aged, 80 and over; alpha-Synuclein; Cognition Disorders; Disease Progression; Family Health; Female; Glutamine; Humans; Longitudinal Studies; Lysine; Male; Mutation; Neuropsychological Tests; Parkinson Disease; Psychiatric Status Rating Scales; Time Factors | 2011 |
Metabolic changes detected by ex vivo high resolution 1H NMR spectroscopy in the striatum of 6-OHDA-induced Parkinson's rat.
Topics: Animals; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Magnetic Resonance Spectroscopy; Male; Multivariate Analysis; Neostriatum; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley | 2013 |
Monomer DJ-1 and its N-terminal sequence are necessary for mitochondrial localization of DJ-1 mutants.
Topics: Amino Acid Substitution; Animals; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cysteine; Cytoplasm; Dimerization; Glutamine; Humans; Membrane Potential, Mitochondrial; Mice; Mitochondria; Mutation; Oncogene Proteins; Oxidative Stress; Parkinson Disease; Peroxiredoxins; Protein Deglycase DJ-1 | 2013 |
Paraoxonase 1 (PON1) gene polymorphisms and Parkinson's disease in a Finnish population.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Aryldialkylphosphatase; Case-Control Studies; DNA Mutational Analysis; Female; Finland; Gene Frequency; Genetic Predisposition to Disease; Genotype; Glutamine; Humans; Leucine; Male; Methionine; Middle Aged; Parkinson Disease; Polymorphism, Genetic | 2004 |
Cerebrospinal fluid from patients with dementia contains increased amounts of an unknown factor.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Case-Control Studies; Choline; Dementia, Vascular; Female; Glutamine; Humans; Huntington Disease; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease | 2004 |
Exclusion of PINK1 as candidate gene for the late-onset form of Parkinson's disease in two European populations.
Topics: Adult; Age of Onset; Aged; Alleles; Cohort Studies; Genotype; Germany; Glutamine; Humans; Middle Aged; Mutation; Norway; Parkinson Disease; Protein Kinases | 2005 |
Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models.
Topics: Animals; Calcium Channels, L-Type; Corpus Striatum; Dendritic Spines; Disease Models, Animal; Glutamine; Mice; Mice, Inbred C57BL; Microscopy, Immunoelectron; Neural Pathways; Organ Culture Techniques; Parkinson Disease; Patch-Clamp Techniques; Reverse Transcriptase Polymerase Chain Reaction; Synapses | 2006 |
Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Arginine; Case-Control Studies; Female; Genetic Predisposition to Disease; Glutamine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Mutation; Parkinson Disease; Protein Serine-Threonine Kinases | 2007 |
Glutamate measurement in Parkinson's disease using MRS at 3 T field strength.
Topics: Antiparkinson Agents; Aspartic Acid; Corpus Striatum; Creatine; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Levodopa; Magnetic Resonance Spectroscopy; Parkinson Disease; Reference Values | 2007 |
Polyglutamine expansion mutation yields a pathological epitope linked to nucleation of protein aggregate: determinant of Huntington's disease onset.
Topics: Age of Onset; Alzheimer Disease; Cell Death; DNA; DNA Primers; DNA Repeat Expansion; Genes, Reporter; Glutamine; Humans; Huntington Disease; Kinetics; Mutation; Parkinson Disease; Peptides; Plasmids; Polylysine; Polymerase Chain Reaction; Transfection | 2007 |
Fasting plasma and CSF amino acid levels in amyotrophic lateral sclerosis: a subtype analysis.
Topics: Amino Acids; Amyotrophic Lateral Sclerosis; Fasting; Female; Glutamates; Glutamine; Hereditary Sensory and Autonomic Neuropathies; Humans; Male; Parkinson Disease; Plasma | 1993 |
Neurotransmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease.
Topics: Aged; Amino Acids; Asparagine; Aspartic Acid; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Glycine; Humans; Male; Middle Aged; Neurotransmitter Agents; Parkinson Disease | 1996 |
A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease.
Topics: Aged; Aspartic Acid; Cerebral Cortex; Choline; Corpus Striatum; Creatine; Female; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Movement Disorders; Parietal Lobe; Parkinson Disease; Reference Values; Temporal Lobe | 1999 |
Gln --> Arg 191 polymorphism of paraoxonase and Parkinson's disease.
Topics: Aged; Alleles; Amino Acid Substitution; Arginine; Aryldialkylphosphatase; Base Sequence; Deoxyribonucleases, Type I Site-Specific; DNA; DNA Restriction Enzymes; Esterases; Gene Frequency; Genotype; Glutamine; Humans; Middle Aged; Parkinson Disease; Polymorphism, Genetic | 1999 |
Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophy measured by proton magnetic resonance spectroscopy.
Topics: Adult; Aged; Aspartic Acid; Basal Ganglia; Choline; Creatine; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Pilot Projects; Reference Values | 2000 |
Excitatory amino acid antagonists and Parkinson's disease.
Topics: Amino Acids; Dopamine; Dopamine and cAMP-Regulated Phosphoprotein 32; Glutamine; Humans; Nerve Tissue Proteins; Parkinson Disease; Phosphoproteins; Phosphorylation | 1990 |
[The effect of the administration of amino acids, especially of L-dopa and alpha-methyldopa, on the composition of cerebrospinal fluid in extrapyramidal syndromes. I. Alterations of cerebrospinal fluid in patients with parkinson's disease and normals].
Topics: Alanine Transaminase; Arginine; Aspartate Aminotransferases; Dihydroxyphenylalanine; Glutamine; Glycine; Humans; Injections, Intravenous; Ketoglutaric Acids; Oxaloacetates; Parkinson Disease | 1969 |